Skip to content

Sana Biotechnology, Inc.

SANA· NasdaqCore metricsCIK 1770121

Biological products, except diagnostic substances175 peers

Last sale
Nov 12, 2026 · -13.04%
Market cap
$599.27M
299.63M shares
Filings
392
—
—
—
$20.40M
Q3 2026N/M FY25 yoy
$18.51M
Q3 2026N/M FY25 yoy
-$111.62M
Q3 2026derivedN/M FY25 yoy
$0.07
Q3 2026N/M FY25 yoy
$41.10M
Q3 2026−43.7% FY25 yoy
$599.27M
—
—
3.3×
-24.16%
—

FY2025 figures · derived

Price

$2.0052.94%$2.25past year
Nov 12, 2026 · IEX last sale
Figure
Range
IEX last saleClose of recordAs traded

Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.

Financials

Research And Development

$131.98MFY 2025
$285.89M0FY 2019FY 2020FY 2021FY 2022FY 2023FY 2024FY 2025
PeriodEndedValueKindSource trail
FY 20252025-12-31$131,980,000reported
FY 20242024-12-31$215,673,000 revisedreported
FY 20232023-12-31$261,809,000 revisedreported
FY 20222022-12-31$285,885,000reported
FY 20212021-12-31$248,626,000reported
FY 20202020-12-31$132,944,000reported
FY 20192019-12-31$99,591,000reported

Biological products, except diagnostic substances

Sana Biotechnology, Inc. is the 60th largest of the 176 covered companies the SEC files under this code, by market cap. SIC 2836

Peers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in market cap first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.

Sana Biotechnology, Inc. · CIK 1770121 · Engraved from SEC EDGAR